2022
DOI: 10.1007/s11655-022-3723-4
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism of Gentisic Acid on Rheumatoid Arthritis Based on miR-19b-3p/RAF1 Axis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…CAV1 [626], TFAP2A [842],TP53 [843], and NFKB1 [844] are the most specific biomarkers for the detection systemic sclerosis. Biomarkers including CAV1 [767], hsa-mir-19b-3p [845], JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [846], STAT1 [847], TP53 [848], and NFKB1 [849] were largely detected in rheumatoid arthritis. CAV1 [797] could be a potential biomarker for scleroderma.…”
Section: Discussionmentioning
confidence: 99%
“…CAV1 [626], TFAP2A [842],TP53 [843], and NFKB1 [844] are the most specific biomarkers for the detection systemic sclerosis. Biomarkers including CAV1 [767], hsa-mir-19b-3p [845], JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [846], STAT1 [847], TP53 [848], and NFKB1 [849] were largely detected in rheumatoid arthritis. CAV1 [797] could be a potential biomarker for scleroderma.…”
Section: Discussionmentioning
confidence: 99%
“…CAV1 [626], TFAP2A [842], TP53 [843] and NFKB1 [844] have been identified as a new potential therapeutic target against systemic sclerosis. CAV1 [767], hsa-mir-19b-3p [845], JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [846], STAT1 [847], TP53 [848] and NFKB1 [849] are reported to promote rheumatoid arthritis. The role of CAV1 [797] in the growth and progression of scleroderma.…”
Section: Discussionmentioning
confidence: 99%
“…Phenolic acids lead to the antioxidant and anti-inflammation properties of H-atom through a mechanism of free radical scavenging [165]. Gallic acid has lots of health effects in bacterial or viral infections, cancer, inflammatory, neuropsychological, gastrointestinal, and metabolic disease, it inhibits bacterial growth by altering membrane structure, inhibits cancer cell growth and oncogenes as well as matrix metalloproteinases expression by targeting different signaling pathways in apoptosis, increasing reactive oxygen species production [166]; Protocatechuic acid has anti-allodynic and anti-hyperalgesic effects by KATP channel activation related with A1 receptor stimulation [167]; gentisic acid regulated miR-19b-3p/RAF1 axis to mediate ERK pathway and inhibit the development of rheumatoid arthritis [168]. Chlorogenic acids regulate key targets in the TNF signaling pathway, inhibit the polarization of microglia to the M1 phenotype, and ameliorates neuroinflammation-induced cognitive dysfunction in mice [169].…”
Section: Phenolic Acids Mechanismmentioning
confidence: 99%